Macquarie Group Ltd

SEC CIK: 0001418333
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overview All 13F holders of VRTX Full Q2 2026 holdings

Shares (Q2 2026): 37,980
Value: $18.9M
% of portfolio: 0.1%
Quarters held: 22; Since Q1 2021

Holdings of VRTX by Macquarie Group Ltd, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	37,980	$18.9M	0.1%	−2,256−5.6%	Reduced	Holders
Q1 2026	40,236	$18.0M	0.1%	−4,500−10.1%	Reduced	Holders
Q4 2025	44,736	$20.3M	0.1%	−178,820−80.0%	Reduced	Holders
Q3 2025	223,556	$87.6M	0.1%	−5,297−2.3%	Reduced	Holders
Q2 2025	228,853	$101.9M	0.1%	−5,283−2.3%	Reduced	Holders
Q1 2025	234,136	$113.5M	0.1%	+4,203+1.8%	Added	Holders
Q4 2024	229,933	$88.7M	0.1%	−96,583−29.6%	Reduced	Holders
Q3 2024	326,516	$151.9M	0.2%	−9,229−2.7%	Reduced	Holders
Q2 2024	335,745	$157.4M	0.2%	−36,496−9.8%	Reduced	Holders
Q1 2024	372,241	$155.6M	0.2%	−25,053−6.3%	Reduced	Holders
Q4 2023	397,294	$161.7M	0.2%	−333,639−45.6%	Reduced	Holders
Q3 2023	730,933	$254.2M	0.3%	+16,498+2.3%	Added	Holders
Q2 2023	714,435	$251.4M	0.3%	−51,939−6.8%	Reduced	Holders
Q1 2023	766,374	$241.5M	0.3%	−92,926−10.8%	Reduced	Holders
Q4 2022	859,300	$248.1M	0.3%	−38,008−4.2%	Reduced	Holders
Q3 2022	897,308	$259.8M	0.3%	−35,871−3.8%	Reduced	Holders
Q2 2022	933,179	$263.0M	0.3%	+652,321+232.3%	Added	Holders
Q1 2022	280,858	$73.3M	0.1%	−23,399−7.7%	Reduced	Holders
Q4 2021	304,257	$66.8M	0.1%	−1,046,258−77.5%	Reduced	Holders
Q3 2021	1,350,515	$245.0M	0.2%	−266,259−16.5%	Reduced	Holders
Q2 2021	1,616,774	$326.0M	0.3%	+1,466,287+974.4%	Added	Holders
Q1 2021	150,487	$32.3M	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.